Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥274m2026-01-01 → 2026-06-30StandaloneNet sales
Revenue¥593m2025-01-01 → 2025-12-31StandaloneNet sales (5-year summary)
Revenue¥252m2025-01-01 → 2025-06-30StandaloneNet sales
Operating income−¥480m2026-01-01 → 2026-06-30StandaloneOperating income
Operating income−¥537m2025-01-01 → 2025-06-30StandaloneOperating income
Ordinary income−¥482m2026-01-01 → 2026-06-30StandaloneOrdinary income
Ordinary income−¥989m2025-01-01 → 2025-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥539m2025-01-01 → 2025-06-30StandaloneOrdinary income
Profit before tax−¥482m2026-01-01 → 2026-06-30StandaloneIncome before income taxes
Profit before tax−¥539m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Net income−¥483m2026-01-01 → 2026-06-30StandaloneProfit loss
Net income−¥983m2025-01-01 → 2025-12-31StandaloneNet income loss (5-year summary)
Net income−¥540m2025-01-01 → 2025-06-30StandaloneProfit loss
Total assets¥1.9bnat 2026-06-30StandaloneAssets
Total assets¥1.7bnat 2025-12-31StandaloneAssets
Total assets¥2.0bnat 2025-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥341mat 2026-06-30StandaloneLiabilities
Total liabilities¥605mat 2025-12-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2026-06-30StandaloneNet assets
Net assets / equity¥1.1bnat 2025-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2025-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.4bnat 2026-06-30StandaloneCash and deposits
Cash and deposits¥1.2bnat 2025-12-31StandaloneCash and deposits
Cash & equivalents¥1.4bnat 2026-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2024-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥539m2026-01-01 → 2026-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥936m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥673m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥4m2026-01-01 → 2026-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥55m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥710m2026-01-01 → 2026-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥133m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥85m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-6.622026-01-01 → 2026-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.472025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.972025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio81.9%at 2026-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.1%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.9%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued78,940,200at 2026-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued68,453,800at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued68,053,800at 2025-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥269m
Drug Discovery And Developmentreportable segmentsegment profit2026-01-01 → 2026-06-30−¥369m
Drug Discovery Supportreportable segmentrevenue2026-01-01 → 2026-06-30¥274m
Drug Discovery Supportreportable segmentrevenue external2026-01-01 → 2026-06-30¥274m
Drug Discovery Supportreportable segmentsegment profit2026-01-01 → 2026-06-30¥159m
Total Of Reportable Segments And Otherssegment totalrevenue2026-01-01 → 2026-06-30¥274m
Total Of Reportable Segments And Otherssegment totalrevenue external2026-01-01 → 2026-06-30¥274m
Total Of Reportable Segments And Otherssegment totalsegment profit2026-01-01 → 2026-06-30−¥210m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥280m
Drug Discovery And Developmentreportable segmentsegment profit2025-01-01 → 2025-06-30−¥396m
Drug Discovery Supportreportable segmentrevenue2025-01-01 → 2025-06-30¥252m
Drug Discovery Supportreportable segmentrevenue external2025-01-01 → 2025-06-30¥252m
Drug Discovery Supportreportable segmentsegment profit2025-01-01 → 2025-06-30¥139m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30−¥257m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 430
ItemContextValueUnit
Accounts receivable tradeInterimInstant_NonConsolidatedMember27631000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember49412000JPY
InventoriesInterimInstant_NonConsolidatedMember72902000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember135015000JPY
Advance payments tradeInterimInstant_NonConsolidatedMember158377000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember29520000JPY
Consumption taxes receivableInterimInstant_NonConsolidatedMember14919000JPY
Other caPrior1YearInstant_NonConsolidatedMember55726000JPY
Other caInterimInstant_NonConsolidatedMember87338000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember1546698000JPY
Current assetsInterimInstant_NonConsolidatedMember1733191000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember250121000JPY
Machinery and equipmentInterimInstant_NonConsolidatedMember247831000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-213781000JPY
Accumulated depreciation machinery and equipmentInterimInstant_NonConsolidatedMember-212588000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember36340000JPY
Machinery and equipment netInterimInstant_NonConsolidatedMember35242000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember79857000JPY
Tools furniture and fixturesInterimInstant_NonConsolidatedMember79857000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-79857000JPY
Accumulated depreciation tools furniture and fixturesInterimInstant_NonConsolidatedMember-79857000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netInterimInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember36340000JPY
Property plant and equipmentInterimInstant_NonConsolidatedMember35242000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember128191000JPY
Lease and guarantee depositsInterimInstant_NonConsolidatedMember128191000JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember16274000JPY
Long term prepaid expensesInterimInstant_NonConsolidatedMember10500000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaInterimInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember144465000JPY
Investments and other assetsInterimInstant_NonConsolidatedMember138691000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember180806000JPY
Noncurrent assetsInterimInstant_NonConsolidatedMember173933000JPY
AssetsPrior1YearInstant_NonConsolidatedMember1727504000JPY
AssetsInterimInstant_NonConsolidatedMember1907125000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember37442000JPY
Accounts payable tradeInterimInstant_NonConsolidatedMember51261000JPY
Short term loans payablePrior1YearInstant_NonConsolidatedMember86700000JPY
Short term loans payableInterimInstant_NonConsolidatedMember67500000JPY
Accounts payable otherPrior1YearInstant_NonConsolidatedMember82517000JPY
Accounts payable otherInterimInstant_NonConsolidatedMember75552000JPY
Accrued expensesPrior1YearInstant_NonConsolidatedMember14555000JPY
Accrued expensesInterimInstant_NonConsolidatedMember11838000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember12553000JPY
Income taxes payableInterimInstant_NonConsolidatedMember12253000JPY
Contract liabilitiesPrior1YearInstant_NonConsolidatedMember130329000JPY
Contract liabilitiesInterimInstant_NonConsolidatedMember60595000JPY
Deposits receivedPrior1YearInstant_NonConsolidatedMember10787000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2025-12-31pass
balance sheet identitynon_consolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net assetsnon_consolidated 2026-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2026-01-01/2026-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2026-06-30pass